Biolife Solutions Inc (NASDAQ:BLFS) price on Friday, February 28, rose 1.78% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $24.00.
A look at the stock’s price movement, the close in the last trading session was $23.58. Turning to its 52-week performance, $29.55 and $14.50 were the 52-week high and 52-week low respectively. Overall, BLFS moved -15.19% over the past month.
Biolife Solutions Inc’s market cap currently stands at around $1.11 billion, with investors looking forward to this quarter’s earnings report slated for in April.
Analysts have a consensus estimate of 21.73M for the company’s revenue for the quarter, with a low and high estimate of 21.02M and 22.67M respectively. The average forecast suggests down to a -33.62% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 99.52M, representing a -30.54% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that BLFS is a Hold. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
4 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 4 recommend BLFS as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
BLFS’s current price about -8.97% and -10.17% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 34.59, while 7-day volatility ratio is 6.47% and 5.11% in the 30-day chart. Further, Biolife Solutions Inc (BLFS) has a beta value of 2.05, and an average true range (ATR) of 1.37. Analysts have given the company’s stock an average 52-week price target of $30, forecast between a low of $30 and high of $30. Looking at the price targets, the low is -25.0% off current price level while to achieve the yearly target high, price needs to move -25.0%. Nonetheless, investors will most likely welcome a -25.0% jump to $30 which is the analysts’ median price.
If we refocus on Biolife Solutions Inc (NASDAQ:BLFS), historical trading data shows that trading volumes averaged 271.01K over the past 3 months. The company’s latest data on shares outstanding shows there are 46.23 million shares.
The 3.24% of Biolife Solutions Inc’s shares are in the hands of company insiders while institutional holders own 102.44% of the company’s shares. Current price change has pushed the stock -7.55% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the BLFS stock continues to rise going into the next quarter.
